Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation

Clinical Effect of Point Mutations in Myelodysplastic Syndromes

Rafael Bejar, Kristen E. Stevenson, Omar Abdel‐Wahab et al. · New England Journal of Medicine · 2011 · 1.6K citations

Medicine, Genetics, Hematology +17

p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias

H. Döhner, Konstanze Fischer, Martin Bentz et al. · Blood · 1995 · 732 citations · Full text

Medicine, Molecular Biology, Oncology +17

p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies

Eric Wattel, Claude Preudhomme, B Hecquet et al. · Blood · 1994 · 581 citations · Full text

Medicine, Hematology, Oncology +16

p53 mutation is associated with progression in follicular lymphomas

CA Sander, Takahiro Yano, HM Clark et al. · Blood · 1993 · 388 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission

Roland B. Walter, Sarah Buckley, John M. Pagel et al. · Blood · 2013 · 357 citations

Medicine, Hematology, Oncology +15